Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Physical activity time, step counts yield similar results
May 21, 2024
Similar benefits were seen for all-cause mortality and cardiovascular disease prevention.
AI-informed health app aids diabetes outcomes
May 15, 2024
The app gives tailored nutrition and health recommendations, which are linked to decreases in HbA1c and heart disease risk.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
Four in 10 adults with diabetes report taking a GLP-1 receptor agonist
May 14, 2024
Even with healthcare insurance, users report difficulty paying for the medication.
Men face more diabetes complications than women
May 17, 2024
The findings were independent of diabetes duration over a 10-year period.
Salt substitution may reduce all-cause, cardiovascular mortality
Apr 08, 2024
A slight reduction was seen in major cardiovascular events; very low certainty of serious adverse events was reported.
Good heart health may protect against cognitive decline in black women
Apr 24, 2024
The finding was seen for processing speed and cardiovascular health in Black women but not white women.
Plant-based diets tied to long-term health benefits
May 15, 2024
The benefits include a better cardiometabolic risk profile as well as lower mortality.